Truist Financial’s IGC Pharma IGC Stock Holding History

Truist Financial’s Portfolio IGC Stock Details IGC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$9.64K	Hold	36,667	–	–	﹤0.01%	2786
2025 Q4	$10.3K	Hold	36,667	–	–	﹤0.01%	2756
2025 Q3	$15.3K	Hold	36,667	–	–	﹤0.01%	2703
2025 Q2	$11.2K	Hold	36,667	–	–	﹤0.01%	2585
2025 Q1	$10.4K	Hold	36,667	–	–	﹤0.01%	2533
2024 Q4	$12.3K	Hold	36,667	–	–	﹤0.01%	2501
2024 Q3	$15.7K	Hold	36,667	–	–	﹤0.01%	2477
2024 Q2	$15.9K	Hold	36,667	–	–	﹤0.01%	2628
2024 Q1	$14.7K	Hold	36,667	–	–	﹤0.01%	2603
2023 Q4	$10.3K	Hold	36,667	–	–	﹤0.01%	2621
2023 Q3	$13.2K	Hold	36,667	–	–	﹤0.01%	2568
2023 Q2	$11.4K	Hold	36,667	–	–	﹤0.01%	2550
2023 Q1	$12.4K	Hold	36,667	–	–	﹤0.01%	2553
2022 Q4	$11.7K	Hold	36,667	–	–	﹤0.01%	2538
2022 Q3	$16K	Hold	36,667	–	–	﹤0.01%	2489
2022 Q2	$19K	Hold	36,667	–	–	﹤0.01%	2604
2022 Q1	$35K	Hold	36,667	–	–	﹤0.01%	2640
2021 Q4	$36K	Sell	36,667 -4,926	-12%	-$6.61K	﹤0.01%	2712
2021 Q3	$61K	Hold	41,593	–	–	﹤0.01%	2659
2021 Q2	$68K	Hold	41,593	–	–	﹤0.01%	2663
2021 Q1	$75K	Buy	41,593 +4,926	+13%	+$8.95K	﹤0.01%	2585
2020 Q4	$57K	Hold	36,667	–	–	﹤0.01%	2501
2020 Q3	$38K	Hold	36,667	–	–	﹤0.01%	2401
2020 Q2	$22K	Hold	36,667	–	–	﹤0.01%	2362
2020 Q1	$18K	Hold	36,667	–	–	﹤0.01%	2333
2019 Q4	$23K	Buy	+36,667	New	+$30K	﹤0.01%	2459

Other funds holding IGC

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Lawood & Co Williamsport, Pennsylvania $148M AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Truist Financial's IGC Position: Q1 2026 in Review

Truist Financial held its IGC Pharma (IGC) position steady in Q1 2026 at 36,667 shares worth $9.64K. The position accounts for ﹤0.01% of the portfolio, ranked #2786.

Truist Financial first reported a position in IGC in Q4 2019 and has held it in 26 quarters since. The position peaked at $75K in Q1 2021. 35 funds tracked by Wall St. Rank hold IGC as of Q1 2026.

Truist Financial held 36,667 shares of IGC Pharma worth $9.64K as of Q1 2026.
Truist Financial left its IGC Pharma share count unchanged in Q1 2026.
IGC Pharma made up ﹤0.01% of Truist Financial's portfolio in Q1 2026, its #2786 holding.
Truist Financial first reported a position in IGC Pharma in Q4 2019 and has held it in 26 quarters since.
Truist Financial's IGC Pharma position peaked at $75K in Q1 2021.
35 funds tracked by Wall St. Rank held IGC Pharma as of Q1 2026.

Based on Truist Financial's 13F filing for Q1 2026, filed 27 Apr 2026.